表紙
市場調査レポート

Arbor Pharmaceuticals, LLC.:製品パイプライン分析

Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 314852
出版日 ページ情報 英文 18 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
Arbor Pharmaceuticals, LLC.:製品パイプライン分析 Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2015
出版日: 2015年05月13日 ページ情報: 英文 18 Pages
概要

Arbor Pharmaceuticals, LLC. は後期段階製品の技術供与、開発および製品化に特化した製薬会社です。同社製品は幅広い治療分野を網羅しており、 心臓学、小児科、神経学、その他の処方薬などを扱っています。

当レポートでは、Arbor Pharmaceuticals, LLC.製品パイプライン分析における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Arbor Pharmaceuticals, LLC.の基本情報

  • Arbor Pharmaceuticals, LLC.の概要
  • 主要情報
  • 企業情報

Arbor Pharmaceuticals, LLC.:R&Dの概要

  • 主な治療範囲

Arbor Pharmaceuticals, LLC.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Arbor Pharmaceuticals, LLC.:パイプライン製品の概況

  • 最終段階にあるパイプライン製品
    • 登録前の製品/併用療法モダリティ
    • 第III相にある製品/併用療法モダリティ
  • 治験段階にあるパイプライン製品
    • 第II相にある製品/併用療法モダリティ
    • 第I相にある製品/併用療法モダリティ

Arbor Pharmaceuticals, LLC.:薬剤プロファイル

  • AR-05
  • AR-01
  • AR-08
  • AR-06

Arbor Pharmaceuticals, LLC.:パイプライン分析

  • 投与経路別

Arbor Pharmaceuticals, LLC.:最近のパイプライン動向

Arbor Pharmaceuticals, LLC.:休止中のプロジェクト

Arbor Pharmaceuticals, LLC.:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07083CDB

Summary

Global Markets Direct's, 'Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2015', provides an overview of the Arbor Pharmaceuticals, LLC.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Arbor Pharmaceuticals, LLC.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Arbor Pharmaceuticals, LLC. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Arbor Pharmaceuticals, LLC.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Arbor Pharmaceuticals, LLC.'s pipeline products

Reasons to buy

  • Evaluate Arbor Pharmaceuticals, LLC.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Arbor Pharmaceuticals, LLC. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Arbor Pharmaceuticals, LLC.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Arbor Pharmaceuticals, LLC. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Arbor Pharmaceuticals, LLC.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Arbor Pharmaceuticals, LLC. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Arbor Pharmaceuticals, LLC. Snapshot
    • Arbor Pharmaceuticals, LLC. Overview
    • Key Information
    • Key Facts
  • Arbor Pharmaceuticals, LLC. - Research and Development Overview
    • Key Therapeutic Areas
  • Arbor Pharmaceuticals, LLC. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Arbor Pharmaceuticals, LLC. - Pipeline Products Glance
    • Arbor Pharmaceuticals, LLC. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
  • Arbor Pharmaceuticals, LLC. - Drug Profiles
      c
    • AR-08
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-06
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • AR-18
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Arbor Pharmaceuticals, LLC. - Pipeline Analysis
    • Arbor Pharmaceuticals, LLC. - Pipeline Products by Route of Administration
  • Arbor Pharmaceuticals, LLC. - Recent Pipeline Updates
  • Arbor Pharmaceuticals, LLC. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Arbor Pharmaceuticals, LLC., Key Information
  • Arbor Pharmaceuticals, LLC., Key Facts
  • Arbor Pharmaceuticals, LLC. - Pipeline by Indication, 2015
  • Arbor Pharmaceuticals, LLC. - Pipeline by Stage of Development, 2015
  • Arbor Pharmaceuticals, LLC. - Monotherapy Products in Pipeline, 2015
  • Arbor Pharmaceuticals, LLC. - Phase II, 2015
  • Arbor Pharmaceuticals, LLC. - Phase I, 2015
  • Arbor Pharmaceuticals, LLC. - Pipeline by Route of Administration, 2015
  • Arbor Pharmaceuticals, LLC. - Recent Pipeline Updates, 2015

List of Figures

  • Arbor Pharmaceuticals, LLC. - Pipeline by Top 10 Indication, 2015
  • Arbor Pharmaceuticals, LLC. - Pipeline by Stage of Development, 2015
  • Arbor Pharmaceuticals, LLC. - Monotherapy Products in Pipeline, 2015
Back to Top